openPR Logo
Press release

Health Canada Recognizes Ecosense And Its Industry-Leading Product Line

12-05-2024 04:08 PM CET | Health & Medicine

Press release from: ABNewswire

Health Canada Recognizes Ecosense And Its Industry-Leading

EcoQube, EcoBlu, and RadonEye are officially approved as trusted radon detection solutions by Health Canada.
San Jose, California - December 5, 2025 - Ecosense Registered , the industry leader in continuous radon monitoring, proudly announces that its consumer-grade Ecosense Digital Radon Monitors [https://ecosense.io/pages/home-solution] have been included on Health Canada's approved list of long-term radon testing devices. This milestone highlights Ecosense's commitment to enhancing radon safety and community well-being by delivering state-of-the-art detection and monitoring solutions for both consumers and professionals. Recognized as a top performer on Health Canada's List of Approved Devices [https://c-nrpp.ca/wp-content/uploads/2023/10/Digital-Device-Report-Oct-2023.pdf], Ecosense earned this distinction based on the 2023 C-NRPP Intercomparison studies.

"Getting approved by Health Canada is a major achievement for Ecosense," said Insoo Park [https://www.linkedin.com/in/insoo-park-2295951/], Founder & CEO at Ecosense Inc. "Ecosense applauds Health Canada's forward-thinking, proactive, and pragmatic decision to recognize the capability of consumer-grade devices for long-term radon testing and monitoring. This recognition highlights the precision, trustworthiness, and creativity of our products. Our goal has continuously been to equip individuals and families with the resources to manage their home radon levels and protect their well-being."

In November, Health Canada's Radon Action Month raised awareness about radon risks and promoted home safety. The updated Residential Measurement Guide now approves consumer-grade electronic radon monitors for home use. Ecosense is proud to have three monitors - EcoBlu, EcoQube, and RadonEye - on Health Canada's approved list, recognized for their accuracy and reliability through rigorous C-NRPP testing.

Health Canada regards radon testing as crucial to reducing the health hazards linked to long-term radon gas exposure, which is known to be the number one reason for lung cancer in nonsmokers. Radon awareness is on the rise. Ecosense is committed to offering high-quality solutions for both commercial and residential requirements. The company invites you to learn more about Ecosense and its product range by visiting its website at www.ecosense.io or checking out what it offers on Amazon's platform [https://www.amazon.com/stores/page/3149A118-E998-4214-A3B0-C77B18201E62?ingress=3].

About Ecosense Registered

Based in the heart of Silicon Valley, Ecosense Registered is a leader and a trusted provider of both professional and consumer radon detection and monitoring solutions that are easy to use, accurate, and fast. The company's intelligent real-time radon detectors utilize a patented detection technology with high accuracy, delivering reliable results in minutes, not days. Ecosense's flagship monitoring product, EcoQube Registered , was named to TIME's List of the 100 Best Inventions of 2021 and recognized as a CES 2021 Innovation Awards Honoree in the health and wellness category. Ecosense's patented ion chamber technology performance has received independent validation from the University of Michigan (Dept. of Nuclear Engineering and Radiological Science) and the Kansas State University Radon Chamber. Both studies concluded that Ecosense's Patented Technology performed comparably to premium research-grade detectors. Additionally, the 2023 Canadian National Radon Proficiency Program (C-NRPP) study on the intercomparison of consumer continuous radon monitors positioned Ecosense Registered as the industry leader in accurate and precise radon detection.

Media Contact
Company Name: Otter PR
Contact Person: Thomas Mustac
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=health-canada-recognizes-ecosense-and-its-industryleading-product-line]
Address:100 E Pine St Suite 110
City: Orlando
State: Florida
Country: United States
Website: http://OtterPR.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Health Canada Recognizes Ecosense And Its Industry-Leading Product Line here

News-ID: 3774278 • Views:

More Releases from ABNewswire

Clostridioides Difficile Infection Market Size in the 7MM was ~USD 500 million in 2024 and It is expected to increase by 2034, estimates DelveInsight
Clostridioides Difficile Infection Market Size in the 7MM was ~USD 500 million i …
DelveInsight's "Clostridioides Difficile Infection Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Clostridioides Difficile Infection, historical and forecasted epidemiology as well as the Clostridioides Difficile Infection therapeutics market trends in the US, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. Discover Key Insights into the Clostridioides Difficile Infection Market with DelveInsight's In-Depth Report @ Clostridioides Difficile Infection Treatment Market Size
Triple Negative Breast Cancer Market Set for Robust Growth Through 2034Innovative therapies and rising incidence drive steady expansion across the US, Europe, and Japan
Triple Negative Breast Cancer Market Set for Robust Growth Through 2034Innovativ …
Driven by rise of immunotherapies, antibody-drug conjugates, and precision-targeted approaches, TNBC market is projected to expand from USD 4.7 billion in 2025 to USD 7.1 billion by 2034, marking a CAGR of 4.7% across the 7MM. Leading players like AstraZeneca, Pfizer, Gilead Sciences, BioNTech, Astellas Pharma are at forefront, advancing next-generation therapies such as ADC platforms, checkpoint inhibitors, and novel vaccines that aim to improve survival outcomes and redefine patient
Limb Girdle Muscular Dystrophy Therapeutics Market Size in the 7MM is expected to increase substantially by 2034, estimates DelveInsight
Limb Girdle Muscular Dystrophy Therapeutics Market Size in the 7MM is expected t …
DelveInsight's " Limb Girdle Muscular Dystrophy Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Limb Girdle Muscular Dystrophy, historical and forecasted epidemiology, as well as the Limb Girdle Muscular Dystrophy Market trends in the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. Discover Key Insights into the Limb Girdle Muscular Dystrophy Market with DelveInsight's In-Depth Report @ Limb Girdle Muscular
Non-Cystic Fibrosis Bronchiectasis Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight
Non-Cystic Fibrosis Bronchiectasis Competitive Landscape 2025: Clinical Trial An …
Non-Cystic Fibrosis Bronchiectasis companies working in the treatment market are NovaBiotics Ltd, Synspira Therapeutics, Parion Sciences, Chiesi Farmaceutic, CSL Behring, Haisco Pharmaceutical, SolAeroMed Inc., AstraZeneca, Zambon SpA, Boehringer Ingelheim, Armata Pharmaceuticals, Renovion, and others. According to DelveInsight's analysis, the global Non-Cystic Fibrosis Bronchiectasis pipeline features over 16 leading companies actively advancing more than 17 therapeutic candidates, with ongoing evaluations of their clinical trials, mechanisms of action, routes of administration, and developmental

All 5 Releases


More Releases for Ecosense

Ecosense Expands U.S. Market with BestBuy.com Launch
Radon Detection Leader Now Makes Complete Line of Smart Digital Radon Monitors Available to American Consumers San Jose, CA - August 28, 2025 - Ecosense [https://ecosense.io/], the global leader in radon detection and monitoring solutions, is pleased to announce that its award-winning residential radon monitors can now be purchased on BestBuy.com in the United States. Following its launch with Best Buy Canada the year before last, this announcement is the second
Ecosense Expands First-of-Its-Kind Radon Library Lending Program Across Pennsylv …
Industry Leader Partners with Local Libraries in One of the Nation's Highest-Risk Radon States. Pittsburgh, PA - August 26th, 2025 - Ecosense [https://ecosense.io/], an industry-leading provider of the best home radon detector [https://www.bobvila.com/articles/how-to-test-for-radon/] available on the market, is delighted to announce the success of its groundbreaking Library Lending Program [https://ecosense.io/pages/library-lending-program?srsltid=AfmBOoqbvEKIryRPlsIA50BBv6Ckh0_T0hFw8XIs3JcRmDPY7jVuQxKw] in Pennsylvania, one of the country's top three states for radon occurrence. The program is now available to public libraries across the
Ecosense Launches New "Radon-Free" Campaign Promotion
One out of every five radon monitors bought using promo code E-RADONFREE is given away to public facilities to assist in detecting and reducing radon exposure San Jose, CA - June 17, 2025 - Ecosense [https://ecosense.io/], creator of the world's most sophisticated radon detection technology, is pleased to introduce its Radon-Free Campaign, a nationwide effort that promotes greater awareness of radon exposure and healthier indoor air. Consumers can take advantage of
Ecosense Launches "My Radon Analysis" for Smart, DIY Radon Testing at Home
The new service translates real-time results into personalized action, eliminating lab fees and service appointments. San Jose, CA - June 12th, 2025 - Ecosense [https://ecosense.io/], the innovator in radon detection technology, is launching My Radon Analysis, a smart new service offered through the EcoQube mobile app. This complimentary feature provides homeowners with a simple, user-friendly, step-by-step do-it-yourself (DIY) radon testing experience, including expert-assisted results and EPA-aligned recommendations in 72 hours -
Ecosense Supports Breath of Hope Ohio Gala to Advance Lung Cancer Research
San Jose, CA - June 5, 2025 - The 2025 Breath of Hope Ohio Gala [https://breathofhopeohio.org/gala] received continued annual support from Ecosense [https://ecosense.io/], the leading innovator in radon detection technology, on Saturday, May 17, 2025. The annual event generated $175,000 for The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute [https://cancer.osu.edu/] (OSUCCC - James) to fund the development of innovative
Boise School District Leads the Way in Radon Safety with Ecosense Radon Technolo …
Boise, Idaho - April 23, 2025 - The Boise School District allied with Ecosense [https://ecosense.io/] to use their smart radon detection and monitoring solutions for conducting district-wide radon testing to establish safer learning environments. The partnership came after elevated amounts of radon had been recorded in a district's junior high school. The district performed tests, which indicated that radon levels in basement classrooms of cafeteria structures varied from 1.9 pCi/L to